BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 16293601)

  • 1. Suicide gene therapy of graft-versus-host disease induced by central memory human T lymphocytes.
    Bondanza A; Valtolina V; Magnani Z; Ponzoni M; Fleischhauer K; Bonyhadi M; Traversari C; Sanvito F; Toma S; Radrizzani M; La Seta-Catamancio S; Ciceri F; Bordignon C; Bonini C
    Blood; 2006 Mar; 107(5):1828-36. PubMed ID: 16293601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics of in vivo elimination of suicide gene-expressing T cells affects engraftment, graft-versus-host disease, and graft-versus-leukemia after allogeneic bone marrow transplantation.
    Rettig MP; Ritchey JK; Prior JL; Haug JS; Piwnica-Worms D; DiPersio JF
    J Immunol; 2004 Sep; 173(6):3620-30. PubMed ID: 15356106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Graft-versus-leukemia effect of HLA-haploidentical central-memory T-cells expanded with leukemic APCs and modified with a suicide gene.
    Casucci M; Perna SK; Falcone L; Camisa B; Magnani Z; Bernardi M; Crotta A; Tresoldi C; Fleischhauer K; Ponzoni M; Gregori S; Caligaris Cappio F; Ciceri F; Bordignon C; Cignetti A; Bondanza A; Bonini C
    Mol Ther; 2013 Feb; 21(2):466-75. PubMed ID: 23299798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Graft-versus-leukemia effect after suicide-gene-mediated control of graft-versus-host disease.
    Litvinova E; Maury S; Boyer O; Bruel S; Benard L; Boisserie G; Klatzmann D; Cohen JL
    Blood; 2002 Sep; 100(6):2020-5. PubMed ID: 12200361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanism for ganciclovir resistance in human T lymphocytes transduced with retroviral vectors carrying the herpes simplex virus thymidine kinase gene.
    Garin MI; Garrett E; Tiberghien P; Apperley JF; Chalmers D; Melo JV; Ferrand C
    Blood; 2001 Jan; 97(1):122-9. PubMed ID: 11133751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-7 and IL-15 allow the generation of suicide gene-modified alloreactive self-renewing central memory human T lymphocytes.
    Kaneko S; Mastaglio S; Bondanza A; Ponzoni M; Sanvito F; Aldrighetti L; Radrizzani M; La Seta-Catamancio S; Provasi E; Mondino A; Nagasawa T; Fleischhauer K; Russo V; Traversari C; Ciceri F; Bordignon C; Bonini C
    Blood; 2009 Jan; 113(5):1006-15. PubMed ID: 18978209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of graft-versus-host disease with maintenance of the graft-versus-leukemia effect in a murine allogeneic transplant model using retrovirally transduced murine suicidal lymphocytes.
    Kornblau SM; Aycox PG; Stephens C; McCue LD; Champlin RE; Marini FC
    Exp Hematol; 2007 May; 35(5):842-53. PubMed ID: 17577932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Herpes simplex virus thymidine kinase gene transfer for controlled graft-versus-host disease and graft-versus-leukemia: clinical follow-up and improved new vectors.
    Verzeletti S; Bonini C; Marktel S; Nobili N; Ciceri F; Traversari C; Bordignon C
    Hum Gene Ther; 1998 Oct; 9(15):2243-51. PubMed ID: 9794208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Administration of herpes simplex-thymidine kinase-expressing donor T cells with a T-cell-depleted allogeneic marrow graft.
    Tiberghien P; Ferrand C; Lioure B; Milpied N; Angonin R; Deconinck E; Certoux JM; Robinet E; Saas P; Petracca B; Juttner C; Reynolds CW; Longo DL; Hervé P; Cahn JY
    Blood; 2001 Jan; 97(1):63-72. PubMed ID: 11133743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of GvHD by suicide-gene transduced donor T lymphocytes: clinical applications in mismatched transplantation.
    Ciceri F; Bonini C; Gallo-Stampino C; Bordignon C
    Cytotherapy; 2005; 7(2):144-9. PubMed ID: 16040393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective T-cell subset ablation demonstrates a role for T1 and T2 cells in ongoing acute graft-versus-host disease: a model system for the reversal of disease.
    Liu J; Anderson BE; Robert ME; McNiff JM; Emerson SG; Shlomchik WD; Shlomchik MJ
    Blood; 2001 Dec; 98(12):3367-75. PubMed ID: 11719376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production and first-in-man use of T cells engineered to express a HSVTK-CD34 sort-suicide gene.
    Zhan H; Gilmour K; Chan L; Farzaneh F; McNicol AM; Xu JH; Adams S; Fehse B; Veys P; Thrasher A; Gaspar H; Qasim W
    PLoS One; 2013; 8(10):e77106. PubMed ID: 24204746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thymidine kinase (TK) gene-transduced human lymphocytes can be highly purified, remain fully functional, and are killed efficiently with ganciclovir.
    Munshi NC; Govindarajan R; Drake R; Ding LM; Iyer R; Saylors R; Kornbluth J; Marcus S; Chiang Y; Ennist D; Kwak L; Reynolds C; Tricot G; Barlogie B
    Blood; 1997 Feb; 89(4):1334-40. PubMed ID: 9028956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donor lymphocytes expressing the herpes simplex virus thymidine kinase suicide gene: detailed immunological function following add-back after haplo-identical transplantation.
    Hashimoto H; Kitano S; Yamagata S; Miyagi Maeshima A; Ueda R; Ito A; Tada K; Fuji S; Yamashita T; Tomura D; Nukaya I; Mineno J; Fukuda T; Mori S; Takaue Y; Heike Y
    Cytotherapy; 2015 Dec; 17(12):1820-30. PubMed ID: 26452983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suicide gene therapy of graft-versus-host disease: immune reconstitution with transplanted mature T cells.
    Cohen JL; Boyer O; Klatzmann D
    Blood; 2001 Oct; 98(7):2071-6. PubMed ID: 11567992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transfer of the HSV-tk gene into donor peripheral blood lymphocytes for in vivo modulation of donor anti-tumor immunity after allogeneic bone marrow transplantation.
    Bordignon C; Bonini C; Verzeletti S; Nobili N; Maggioni D; Traversari C; Giavazzi R; Servida P; Zappone E; Benazzi E
    Hum Gene Ther; 1995 Jun; 6(6):813-9. PubMed ID: 7548281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TK.007: A novel, codon-optimized HSVtk(A168H) mutant for suicide gene therapy.
    Preuss E; Treschow A; Newrzela S; Brücher D; Weber K; Felldin U; Alici E; Gahrton G; von Laer D; Dilber MS; Fehse B
    Hum Gene Ther; 2010 Aug; 21(8):929-41. PubMed ID: 20201626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ganciclovir-mediated elimination of HSV-Tk+ T cells and cure of graft-vs-host disease in an allogeneic bone marrow transplantation model in the rat.
    Weijtens M; van Spronsen A; Hagenbeek A; de Weger R; Martens A
    Exp Hematol; 2004 Oct; 32(10):962-9. PubMed ID: 15504552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-7 receptor expression identifies suicide gene-modified allospecific CD8+ T cells capable of self-renewal and differentiation into antileukemia effectors.
    Bondanza A; Hambach L; Aghai Z; Nijmeijer B; Kaneko S; Mastaglio S; Radrizzani M; Fleischhauer K; Ciceri F; Bordignon C; Bonini C; Goulmy E
    Blood; 2011 Jun; 117(24):6469-78. PubMed ID: 21531977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of transgene-specific immune responses that limit the in vivo persistence of adoptively transferred HSV-TK-modified donor T cells after allogeneic hematopoietic cell transplantation.
    Berger C; Flowers ME; Warren EH; Riddell SR
    Blood; 2006 Mar; 107(6):2294-302. PubMed ID: 16282341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.